Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Unknown 3 Not yet recruiting 3 Recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Cyclophosphamide 390 Carboplatin 344 Gemcitabine 332 pembrolizumab 329 Cisplatin 328 Paclitaxel 297 Radiotherapy 296 Docetaxel 286 Bevacizumab 253 Rituximab 234 Capecitabine 223 Nivolumab 220 Dexamethasone 206 Fluorouracil 190 fludarabine 177 Oxaliplatin 177 Pemetrexed 153 Doxorubicin 153 Irinotecan 148 Leucovorin 144 Etoposide 144 Cytarabine 133 Cetuximab 129 Bortezomib 129 fludarabine phosphate 128 Lenalidomide 126 Erlotinib Hydrochloride 120 Filgrastim 119 Temozolomide 113 Radiosurgery 113

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × pirfenidone × Clear all

NCT04243837 2024-04-23

LYT-100 in Patients With BCRL

PureTech

Phase 2 Terminated

50 enrolled 9 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡